Back to search
Anticoagulant Reversal
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anticoagulant Reversal trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Anticoagulant Reversal trials you may qualify forThis is a feasibility study of uninterrupted warfarin with a one time dose of Vitamin K before a surgical procedure.
Spontaneous intracerebral haemorrhage (ICH) accounts for approximately 10-15% of all strokes but stands for 50% of stroke-related morbidity and mortality. Appro…
Gastrointestinal bleeding (GIB) is a common emergency in hepatology and gastroenterology, with an overall mortality rate ranging from 5% to 10% depending on the…
This is a single-center, randomized,double-blind, placebo-controlled Phase I study to evaluate safety, PK and PD of single ascending dose (SAD) of MT1011 inject…
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ciraparantag for reversal of anticoagulation induced by different an…
The purpose of this research study is to see how well an experimental freeze dried plasma product, known as FDP, works to reverse the anticoagulation effects of…
The primary purpose of this study is to evaluate the reversal of the anticoagulant effects of milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) and…